| Name | N-[1-(2-fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-carboxamide |
|---|---|
| Synonyms |
trans-N-[1-(2-Fluorphenyl)-1H-pyrazol-3-yl]-1'-oxospiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-cboxamide
MK-0557, 10 mM in DMSO UNII-HVE36P8422 trans-N-(1-(2-Fluorophenyl)-1H-pyrazol-3-yl)-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-cboxamide MK0557;MK 0557 (1r,4r)-N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-cboxamide Spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-cboxamide, N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxo-, trans N-[1-(2-fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-cboxamide (1r,4r)-N-(1-(2-fluorophenyl)-1H-pyrazol-3-yl)-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-cboxamide (1s,4s)-n-(1-(2-fluorophenyl)-1h-pyrazol-3-yl)-1'-oxo-1'h-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-cboxamide N'-Dicyanomethylene-N-(2,4,5-trichloro-phenyl)-hydrazinecboxylic acid ethyl ester MK-0557 MK0557,Neuroptide Y Rector,inhibit,MK 0557,Inhibitor,NPY rector,MK-0557 1'-cyclohexane]-4'-carboxamide |
| Description | MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM. |
|---|---|
| Related Catalog | |
| Target |
Ki: 1.6 nM (Y5)[1] |
| In Vitro | MK-0557 antagonizes the effects of the NPY5R-selective agonist on body-weight gain and hyperphagia in C57BL/6J mice and significantly suppresses the body-weight gain in diet-induced obese (DIO) mice. When lean mice on regular chow are switched to a medium high-fat diet (4.2 kcal/g) and treated with MK-0557 at 30 mg/kg PO QD, MK-0557 causes a 40% reduction inbody-weight gain at day 35[2]. |
| References |
| Molecular Formula | C22H19FN4O3 |
|---|---|
| Molecular Weight | 406.41000 |
| Exact Mass | 406.14400 |
| PSA | 89.34000 |
| LogP | 3.02290 |
| Storage condition | 2-8℃ |
| Precursor 6 | |
|---|---|
| DownStream 0 | |